Deciphering the Genetics of Cardiovascular Disease
The Guo Lab studies the genetic and epigenetic mechanisms of cardiovascular disease and cardiac development, using CRISPR screening and editing, single-cell sequencing, human iPSC-derived 2D cardiomyocytes and 3D cardiac organoids, animal studies, and bioinformatics, toward precision medicine for cardiovascular disease.
Deciphering Variant Pathogenicity
The Guo Lab works to decipher how pathogenic variants — including variants of uncertain significance — cause cardiovascular disease, combining genetics with CRISPR-edited stem-cell models.
About Guo LabOur Research
The Guo Lab’s research spans monogenic and polygenic cardiovascular diseases, congenital heart disease, and endogenous retroviruses in heart development and disease.
Featured Publications
Recent publications highlight groundbreaking findings on the genetic mechanisms of heart disease, novel therapeutic approaches for heart failure, and innovative strategies for improving cardiovascular health outcomes.
Mentorship and Training
The Guo Lab welcomes applications for postdoctoral fellow, research assistant, and graduate / MD-PhD student positions. To apply, contact Dr. Hongchao Guo at hongchao.guo@hsc.utah.edu.
Get Involved
